New report, “UK In Vitro Diagnostics Market Outlook to 2016″ provides key market data on the UK In Vitro Diagnostics (IVD) market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories – clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
– Market size and company share data for In Vitro Diagnostics (IVD) market categories – clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology. – Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within seven market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016. – 2009 company shares and distribution shares data for each of the seven market categories. – Global corporate-level profiles of key companies operating within the UK In Vitro Diagnostics (IVD) market. – Key players covered include Roche, Siemens Healthcare, Abbott, Beckman Coulter, Biomerieux, Ortho-Clinical Diagnostics, and Becton, Dickinson.
Reasons to buy
– Develop business strategies by identifying the key market categories and segments poised for strong growth. – Develop market-entry and market expansion strategies. – Design competition strategies by identifying who-stands-where in the UK In Vitro Diagnostics (IVD) competitive landscape. – Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future. – What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
Beckman Coulter, Inc. – SWOT Analysis company profile is the essential source for top-level company data and information. Beckman Coulter, Inc. – SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Beckman Coulter is engaged in the design, manufacture and marketing of biomedical testing instrument systems, tests and supplies. Its products are used in a range of applications, including medical research, clinical trials and drug discovery, and diagnostic laboratories in hospitals. The company primarily operates in the US, Europe and Asia Pacific regions. It is headquartered in Brea, California and employed about 11,800 people as of December 2009. The company recorded revenues of $3,260.6 million during the financial year (FY) ended December 2009, an increase of 5.2% over FY2008. The operating profit of the company was $231.2 million during FY2009, a decrease of 18.7% over FY2008. The net profit of the company was $147.1 million in FY2009, a decrease of 20.9% over FY2008.
Scope of the Report
- Provides all the crucial information on Beckman Coulter, Inc. required for business and competitor intelligence needs - Contains a study of the major internal and external factors affecting Beckman Coulter, Inc. in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of Beckman Coulter, Inc. -Data is supplemented with details on Beckman Coulter, Inc. history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Beckman Coulter, Inc.
Reasons to Purchase
- Support sales activities by understanding your customers’ businesses better - Qualify prospective partners and suppliers - Keep fully up to date on your competitors’ business structure, strategy and prospects - Obtain the most up to date company information available
Table of Contents : SWOT COMPANY PROFILE: Beckman Coulter, Inc. Key Facts: Beckman Coulter, Inc. Company Overview: Beckman Coulter, Inc. Business Description: Beckman Coulter, Inc. Company History: Beckman Coulter, Inc. Key Employees: Beckman Coulter, Inc. Key Employee Biographies: Beckman Coulter, Inc. Products & Services Listing: Beckman Coulter, Inc. Products & Services Analysis: Beckman Coulter, Inc. SWOT analysis: Beckman Coulter, Inc. *Strengths: Beckman Coulter, Inc. *Weaknesses: Beckman Coulter, Inc. *Opportunities: Beckman Coulter, Inc. *Threats: Beckman Coulter, Inc. Company View: Beckman Coulter, Inc. Top Competitors: Beckman Coulter, Inc. Location and Subsidiary: Beckman Coulter, Inc. *Head Office: Beckman Coulter, Inc. *Other Locations and Subsidiaries: Beckman Coulter, Inc.
New report, “Brazil In Vitro Diagnostics Market Outlook to 2016″ provides key market data on the Brazil In Vitro Diagnostics (IVD) market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories – clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
– Market size and company share data for In Vitro Diagnostics (IVD) market categories – clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology. – Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within seven market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016. – 2009 company shares and distribution shares data for each of the seven market categories. – Global corporate-level profiles of key companies operating within the Brazil In Vitro Diagnostics (IVD) market. – Key players covered include Roche, Siemens Healthcare, Abbott, Beckman Coulter, Biomerieux, Ortho-Clinical Diagnostics, and Becton, Dickinson.
Reasons to buy
– Develop business strategies by identifying the key market categories and segments poised for strong growth. – Develop market-entry and market expansion strategies. – Design competition strategies by identifying who-stands-where in the Brazil In Vitro Diagnostics (IVD) competitive landscape. – Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future. – What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
This product may be an accessory for Allegra X-12 and X-12R Benchtop Centrifuges, Beckman Coulter and may differ from the image shown. If you have any concerns, please contact us prior to placing your order.
Product Description Streamline cell and general separations with the Allegra X-12 series benchtop centrifuges. They feature a numerical key pad for easy and quick value entry, and they control temperature for up to 10 minutes after the rotor has stopped for walk-away flexibility. An automatic initial soft start ensures sample integrity. The centrifuges have a brushless induction drive, 10 user-defined programs, 10 independent acceleration profiles and 11 independent deceleration profil… More >>Allegra X-12r, Refrigerated Model – Allegra X-12 And X-12r Benchtop Centrifuges, Beckman Coulter
New report, “Netherlands In Vitro Diagnostics Market Outlook to 2016″ provides key market data on the Netherlands In Vitro Diagnostics (IVD) market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories – clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
– Market size and company share data for In Vitro Diagnostics (IVD) market categories – clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology. – Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within seven market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016. – 2009 company shares and distribution shares data for each of the seven market categories. – Global corporate-level profiles of key companies operating within the Netherlands In Vitro Diagnostics (IVD) market. – Key players covered include Roche, Siemens Healthcare, Abbott, Beckman Coulter, Biomerieux, Ortho-Clinical Diagnostics, and Becton, Dickinson.
Reasons to buy
– Develop business strategies by identifying the key market categories and segments poised for strong growth. – Develop market-entry and market expansion strategies. – Design competition strategies by identifying who-stands-where in the Netherlands In Vitro Diagnostics (IVD) competitive landscape. – Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future. – What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
New report, “Canada In Vitro Diagnostics Market Outlook to 2016″ provides key market data on the Canada In Vitro Diagnostics (IVD) market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories – clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
– Market size and company share data for In Vitro Diagnostics (IVD) market categories – clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology. – Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within seven market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016. – 2009 company shares and distribution shares data for each of the seven market categories. – Global corporate-level profiles of key companies operating within the Canada In Vitro Diagnostics (IVD) market. – Key players covered include Roche, Siemens Healthcare, Abbott, Beckman Coulter, Biomerieux, Ortho-Clinical Diagnostics, and Becton, Dickinson.
Reasons to buy
– Develop business strategies by identifying the key market categories and segments poised for strong growth. – Develop market-entry and market expansion strategies. – Design competition strategies by identifying who-stands-where in the Canada In Vitro Diagnostics (IVD) competitive landscape. – Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future. – What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
This is the first part of a series of instructional videos for the Supramolecular Sensors Stream about the HPLC. HPLC shown is the Beckman Coulter System Gold 126 that was refurbished from the Anslyn research group.
New report, “Italy In Vitro Diagnostics Market Outlook to 2016″ provides key market data on the Italy In Vitro Diagnostics (IVD) market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories – clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
– Market size and company share data for In Vitro Diagnostics (IVD) market categories – clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology. – Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within seven market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016. – 2009 company shares and distribution shares data for each of the seven market categories. – Global corporate-level profiles of key companies operating within the Italy In Vitro Diagnostics (IVD) market. – Key players covered include Roche, Siemens Healthcare, Abbott, Beckman Coulter, Biomerieux, Ortho-Clinical Diagnostics, and Becton, Dickinson.
Reasons to buy
– Develop business strategies by identifying the key market categories and segments poised for strong growth. – Develop market-entry and market expansion strategies. – Design competition strategies by identifying who-stands-where in the Italy In Vitro Diagnostics (IVD) competitive landscape. – Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future. – What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
Callahan & Blaine is California’s Premier Litigation Firm. Founded in 1984, Callahan & Blaine has been achieving record-breaking verdicts and settlements for over 25 years in all areas of complex litigation. For example, Callahan & Blaine has the highest jury verdict in Orange County history, a $934 million jury verdict achieved after a three-month trial in Beckman Coulter v. Flextronix, a complex business litigation case. Likewise, in a complex of municipal liability cases, Callahan & Blaine obtained a $50 million settlement that has been certified by West Trial Digest as the largest personal injury settlement in the history of the United States.
